Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $87.25 USD
Change Today -1.01 / -1.15%
Volume 72.3K
ICUI On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

icu medical inc (ICUI) Key Developments

ICU Medical Seeks Acquisitions

Scott Lamb, Chief Financial Officer of ICU Medical, Inc. (NasdaqGS:ICUI) said, "I am not sure there is much to add to what Allison already mentioned on capital deployment. In the fourth quarter, as you know, we talked about a deal that we are working on, and we will continue to try and fill our pipeline of potential acquisition targets, whether it's through tuck-ins or something much more significant than that. But we are going to be disciplined about it, and we are not going to just jump into something for the sake of spending our cash. So I think that just goes right along in line with what Allison mentioned."

ICU Medical, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 02:15 PM

ICU Medical, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 02:15 PM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, FL 32837, United States.

ICU Medical, Inc. Presents at 27th Annual ROTH Conference, Mar-09-2015 09:30 AM

ICU Medical, Inc. Presents at 27th Annual ROTH Conference, Mar-09-2015 09:30 AM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States.

ICU Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Fiscal Year of 2015

ICU Medical, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the full year, the company reported net sales of $308,770,000 compared to $313,056,000 a year ago. Total revenue was $309,260,000 compared to $313,716,000 a year ago. Income from operations was $39,037,000 compared to $51,949,000 a year ago. Income before income taxes was $39,792,000 compared to $52,714,000 a year ago. Net income was $26,335,000 compared to $40,418,000 a year ago. Diluted net income per share was $1.68 compared to $2.65 a year ago. Net cash provided by operating activities was $60,640,000 compared to $65,726,000 a year ago. Purchases of property and equipment were $16,604,000 compared to $18,415,000 a year ago. Intangible asset additions were $989,000 compared to $1,080,000 a year ago. Adjusted EBITDA was $73,924,000 compared to $79,024,000 a year ago. Adjusted diluted earnings per share were $2.38 compared to $3.06 a year ago. For the fourth quarter, the company reported net sales of $79,773,000 compared to $77,637,000 a year ago. Total revenue was $79,896,000 compared to $77,941,000 a year ago. Income from operations was $12,053,000 compared to $13,558,000 a year ago. Income before income taxes was $12,236,000 compared to $13,753,000 a year ago. Net income was $7,372,000 compared to $13,332,000 a year ago. Diluted net income per share was $0.46 compared to $0.86 a year ago. Adjusted EBITDA was $21,896,000 compared to $20,138,000 a year ago. Adjusted diluted earnings per share were $0.68 compared to $0.94 a year ago. The company provided earnings guidance for the fiscal year of 2015. For the period, the company expects revenue to be in the range of $312 million to $317 million; GAAP diluted earnings per share to be in the range of $2.15 to $2.25, adjusted diluted earnings per share to be in the range of $2.70 to $2.80, and adjusted EBITDA to be in the range of $84 million to $86 million.

ICU Medical, Inc. to Report Q4, 2014 Results on Feb 09, 2015

ICU Medical, Inc. announced that they will report Q4, 2014 results at 4:00 PM, US Eastern Standard Time on Feb 09, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICUI:US $87.25 USD -1.01

ICUI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $17.08 USD -0.02
Cyberonics Inc $63.72 USD +0.83
NxStage Medical Inc $19.05 USD -0.35
Orthofix International NV $35.96 USD -0.50
Wright Medical Group Inc $26.07 USD -0.19
View Industry Companies
 

Industry Analysis

ICUI

Industry Average

Valuation ICUI Industry Range
Price/Earnings 52.4x
Price/Sales 4.4x
Price/Book 2.7x
Price/Cash Flow 52.4x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICU MEDICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.